Under the medical cannabis trial, rolled out in March 2021, patients suffering from serious pathologies were prescribed active cannabis-derived substances in the form of essential oils to be taken orally, or of cannabis flowers for vaping.
The experiement was due to end on 31 December 2024, but at a meeting on Thursday between patient associations and the health authorities, the Ministry of Health gave the green light for it to run for a further six months, FranceInfo reported.
The extension will be granted only "with a view to weaning patients off the drug or finding alternatives", the resigning Health Minister, Geneviève Darrieussecq, wrote in the letter enabling the decision.
